• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of nihpaAbout Author manuscriptsSubmit a manuscriptNIH Public Access; Author Manuscript; Accepted for publication in peer reviewed journal;
Nat Med. Author manuscript; available in PMC Dec 1, 2010.
Published in final edited form as:
Published online May 30, 2010. doi:  10.1038/nm.2159
PMCID: PMC2909583
NIHMSID: NIHMS199347

BASOPHILS AND THE T HELPER 2 ENVIRONMENT CAN PROMOTE THE DEVELOPMENT OF LUPUS NEPHRITIS

Summary

In systemic lupus erythematosus (SLE) self-reactive antibodies can target the kidney (lupus nephritis) leading to functional failure and possible mortality. We report that activation of basophils by autoreactive IgE, causes their homing to lymph nodes, promoting TH2 cell differentiation, and enhancing the production of self-reactive antibodies that cause lupus-like nephritis in Lyn−/− mice. SLE patients also have elevated serum IgE, self-reactive IgE's, and activated basophils that express CD62L and the MHC Class II molecule, HLA-DR; parameters that were found to be associated with increased disease activity and active lupus nephritis. Basophils were also present in the lymph nodes and spleen of SLE patients. Thus, in Lyn−/− mice, basophils and IgE autoantibodies amplify autoantibody production that leads to lupus nephritis, and in SLE patients, the presence of IgE autoantibodies and activated basophils are factors associated with disease activity and nephritis.

Systemic lupus erythematosus (SLE) is a complex disease affecting various organs and may result in death when kidney damage (lupus nephritis) is severe1,2. Lupus nephritis is characterized by IgM-, IgG- and IgA-containing immune complexes deposited in the glomeruli. These immune complexes are formed by autoantibodies with specificity to nuclear components (ANA) or to nucleic acids (double stranded DNA (dsDNA)). However, little is known about how B cells are activated in SLE and thus, increased understanding of this process may uncover novel therapeutic strategies.

While there is considerable evidence for the role of TH1, TH17, and regulatory T cells (Tregs) in SLE310, several studies suggest a possible TH2 contribution1113. As a disease with a strong humoral response14,15, it seems reasonable that SLE may have a TH2 component and increases in immunoglobulin E (IgE) as well as the presence of autoreactive IgE in the sera of some SLE patients have been reported16, without associated increased atopy or allergy. Nonetheless, there is considerable uncertainty as to whether TH2 cytokines (like IL-4) and IgE contribute in SLE and what cell type might be responsible for such contribution.

We and others1719 have previously reported that mice deficient in the Src family protein tyrosine kinase Lyn (Lyn−/−) developed a strong and constitutive TH2 skewing in early life and show exacerbated responses to TH2 challenges. In late life, Lyn−/− mice develop an autoimmune disease that mimics some of the features of human SLE2022. Lyn−/− mice have circulating autoantibodies to double stranded DNA (dsDNA) and other nuclear antigens (ANA). A marked glomerular deposition of circulating immune complexes (CIC) is seen, which results in kidney damage and ultimately in death. Interestingly, a genetic association of Lyn with SLE, in a European-American population, was recently reported23. Additionally, B cells from some SLE patients have also been found to express reduced levels of Lyn kinase24. Thus, Lyn−/− mice provide a reasonable model to explore the influence of a TH2 environment on the development of lupus-like nephritis.

Given the aforementioned uncertainty, we explored whether the TH2 skewing of Lyn−/− mice plays a role in the development of late life lupus-like nephritis and whether similar characteristics might be seen in SLE patients. We found that the TH2 phenotype is a contributory factor in the development of lupus-like nephritis in Lyn−/− mice and is also associated with lupus nephritis in human SLE. Importantly, the findings identify basophils and self-reactive IgE as key components that play a role in the development of autoantibody-mediated kidney disease.

Results

IL-4- and IgE-dependent lupus-like nephritis in Lyn−/− mice

Consistent with our prior results18, basophil-dependent TH2-skewing was still present in aged Lyn−/− mice (Supplementary Figure 1) that develop an SLE-like disease. To study the importance of the TH2 environment in the development of the SLE-like phenotype, mice deficient in both IgE and Lyn (Igh7−/−Lyn−/−), IL-4 and Lyn (Il-4−/−Lyn−/−), as well as mast cells and Lyn (KitW-sh/W-shLyn−/−) were used18. Igh7−/−Lyn−/−, Il-4−/−Lyn−/− and KitW-sh/W-shLyn−/− mice developed a peripheral B cell defect that was comparable to Lyn−/− mice and showed hyper IgM and IgA levels in the serum (Supplementary Fig. 2−6), demonstrating that IL-4 or IgE were not involved in these abnormalities. As shown in Supplementary Fig. 5, the level of IgE and IgG isotypes in Igh7−/−Lyn−/− and Il-4−/−Lyn−/− mice were associated with the phenotype reported for Igh7 and Il-4 single deficient mice25,26 and differed from Lyn−/− mice phenotype. IgE also contributed to the previously reported17 increase in mast cell numbers seen in Lyn−/− mice (Supplementary Fig. 7), consistent with a role for IgE in mast cell survival27,28. In contrast, the previously described basophilia in Lyn−/− mice was independent of both IL-4 and IgE18 (Supplementary Fig. 7).

Unlike Lyn−/− and KitW-sh/W-shLyn−/− mice, Igh7−/−Lyn−/− and Il-4−/−Lyn−/− mice did not develop glomerulonephritis (Fig. 1a,b and Supplementary Fig. 8). Glomerular deposits of circulating immune complexes (CIC) containing IgG (Fig. 1c), IgM, IgA and complement factor 3 (C3) (Supplementary Fig. 9a–c) were markedly reduced in the kidney's of Igh7−/−Lyn−/− and Il-4−/−Lyn−/− mice, but were still present in the kidney's of KitW-sh/W-shLyn−/− at comparable levels to Lyn−/− mice (Fig. 1c and Supplementary Fig. 9a–c). Kidney function (as measured by the albumin/creatinine ratio (ACR) in the urine) was rescued in Igh7−/−Lyn−/− and Il-4−/−Lyn−/− mice, whereas the ACR was similarly elevated in both KitW-sh/W-shLyn−/− and Lyn−/− mice (Fig. 1d). These findings show that the lupus-like nephritis observed in Lyn−/− mice is dependent on IgE and IL-4, but is independent of mast cells.

Figure 1
The lupus-like nephritis of Lyn−/− mice is IL-4 and IgE dependent. (a) H&E stained histological kidney sections from aged mice (over 40 weeks) of the indicated genotype were scored for glomerulonephritis as indicated in methods. ...

Basophils support autoreactive plasma cells in Lyn−/− mice

Aged Lyn−/− mice produce large amounts of autoantibodies against dsDNA and nuclear antigens (Fig. 2a, b), which are at the origin of the damage seen in the kidney29,30. We explored if the recovery of kidney function in Igh7−/−Lyn−/− and Il-4−/−Lyn−/− mice was associated with a concomitant decrease in autoantibody production and found a two fold decrease in anti-dsDNA and ANA when compared to Lyn−/− and KitW-sh/W-shLyn−/− mice (Fig. 2a, b). Depletion of basophils in aged Lyn−/− mice (>32 weeks) or in younger KitW-sh/W-shLyn−/− mice (~20 weeks) showed a marked reduction in ANA autoantibodies (Fig. 2c, d). Loss of basophils also decreased the proportion of plasma cells in the spleen (Fig. 2e) and reduced the pro-inflammatory environment in the kidney (Fig. 2f and Supplementary Fig. 10). Collectively, the findings show that basophils support plasma cells in the spleen and amplify the production of autoantibodies in an IL-4 and IgE-dependent manner, leading to a pro-inflammatory environment and kidney disease in Lyn−/− mice.

Figure 2
IgE, basophils, and IL-4 regulate autoantibody production in Lyn−/− mice and basophils promote the kidney cytokine environment. (a) Quantitation of IgG anti-dsDNA in the serum of aged mice (40 weeks) of the indicated genotype. Data are ...

Lyn−/− mice produce basophil-activating self-reactive IgE

Our findings showed the IgE dependence of the SLE-like phenotype, thus we investigated if self-reactive IgE that might activate FcεRI-bearing basophils could be found in the circulation of these mice. Sera from Lyn−/− and KitW-sh/W-shLyn−/− mice had high levels of IgE anti-dsDNA (Fig. 3a) and IgE anti-ANA (data not shown) as compared to their WT counterparts. The presence of self-reactive IgEs was reduced in Il-4−/−Lyn−/− mice and as expected were not detected in Igh7−/−Lyn−/− mice (Fig. 3a). CIC were purified as previously described31 and IgE-containing CIC (IgE-CIC) were found in varying amounts in all the sera from Lyn−/− and KitW-sh/W-shLyn−/− mice (Fig. 3b and Supplementary Fig. 11a,d), whereas the sera of Il-4−/−Lyn−/− and Igh7−/−Lyn−/− mice was essentially void of IgE-CIC (Fig. 3b and Supplementary Fig. 11d). IgG-containing (IgG-CIC)- as well as IgM and IgA containing- CIC were observed in all the mutant strains of mice, but a marked reduction of these CICs was also observed in Il-4−/−Lyn−/− and Igh7−/−Lyn−/− mice, correlating with the reduced amount of autoantibodies found in these mice (Fig. 3c and Supplementary Fig. 11b, c, e). We next examined if IgE or IgG ICs could stimulate basophil IL-4 production. While IgG-ICs failed to stimulate basophil IL-4 production, IgE-ICs were able to induce IL-4 production by basophils (Fig. 3d and Supplementary Fig. 12a, b). Moreover, basophils from Lyn−/− mice showed increased sensitivity to IgE-ICs as compared to their WT counterparts (Fig. 3d and Supplementary Fig. 12a). Importantly, all of the stimuli tested (PMA/Ionomycin, IgE-antigen (Ag), IgE-ICs and IgG-ICs) failed to induce IL-12p40 or IFN-γ production by basophils from WT or Lyn−/− mice (Supplementary Fig. 12c, d). The findings demonstrate that the presence of IgE-ICs (which are present as circulating IgE CICs in Lyn−/− mice) can lead to basophil activation and selective TH2 cytokine expression.

Figure 3
Autoreactive IgE and IgE-circulating immune complexes (IgE-CIC) are present in the sera of aged Lyn−/− mice. (a) Anti-dsDNA IgE in the sera of aged mice (40 weeks), of the indicated genotype, was determined by semi-quantitative ELISA. ...

Lyn−/− basophils express immunoregulatory molecules

We next explored if basophils can home to the secondary lymphoid tissues of Lyn−/− mice where they might influence B and T cell responses. Circulating basophils from Lyn−/− mice showed increased expression of CD62L (L-Selectin) (Fig. 4a), which allows for the homing of leukocytes to secondary lymphoid tissues. In the context of Lyn-deficiency, the absence of IL-4 or IgE (Il-4−/−Lyn−/− and Igh7−/−Lyn−/− mice), but not of mast cells (KitW-sh/W-shLyn−/− mice), inhibited the expression of CD62L on circulating basophils (Fig. 4b). As shown in Fig. 4c and d, Lyn−/− mice had high levels of basophils in both the lymph nodes (cervical and inguinal) and spleen. In the lymph nodes, the constitutive presence of basophils was markedly reduced when IL-4 or IgE were also absent (Il-4−/−Lyn−/− and Igh7−/−Lyn−/− mice) but not when mast cells where absent (KitW-sh/W-shLyn−/− mice) (Fig. 4c). Some reduction was also seen in the spleen but it was not as marked as in the lymph nodes (Fig. 4d). As expected, due to the basophilia seen in the absence of Lyn, no change in the proportion of circulating basophils was observed for any of the strains studied (Fig. 4e). We also found that lymph node resident basophils expressed membrane associated BAFF (Fig. 4f), which was not accounted for by the low levels of BAFF receptor expressed on these cells (data not shown), demonstrating the potential of lymph node resident basophils to influence B cell survival and differentiation. Moreover, both lymph node- (Fig. 4g) and spleen- (Supplementary Fig. 13) localized basophils from Lyn−/− mice showed increased MHC II expression. These findings demonstrate that Lyn−/− basophils upregulate CD62L expression and home to the lymph nodes and spleen, where increased expression of MHC II3234 and/or BAFF may allow communication with T and B cells.

Figure 4
Basophils from aged Lyn−/− mice upregulate CD62L expression, home to secondary lymphoid tissues, and express membrane BAFF and MHC II. (a) Representative flow cytometric analysis of blood basophil CD62L expression in aged (40 weeks) WT ...

Self-reactive IgE is associated with SLE and lupus nephritis

The cohort of SLE patients analyzed had large amounts of C1q-reactive CIC that can fix complement (Fig. 5a), as previously described2,30. When analyzed relative to disease activity (based on SLEDAI score)35, CIC (C1q) is strongly elevated in mild (SLEDAI of 1.0–4.0) and active disease (SLEDAI of > 4.0). SLE patients also had self-reactive IgEs recognizing dsDNA and their levels were associated with increased disease activity (Fig. 5b). IgG directed towards IgE (IgG anti-IgE) was also present in the sera of SLE patients (Fig. 5c) with significantly elevated levels in patients with active disease. IgE anti-dsDNA levels were found to be highly associated with active lupus nephritis (Fig. 5d). Moreover, total IgE levels were increased in patients and were associated with disease activity, and patients showed a modest to strong IgG1, IgG3 and IgE autoantibody response (Supplementary Fig. 14a–c). Thus, the findings show that SLE patients have both TH1 and TH2 autoantibodies and self-reactive IgE's and IgG anti-IgE antibodies that are associated with increased disease activity and active nephritis.

Figure 5
IgE anti-dsDNA and IgG anti-IgE are associated with human SLE disease activity and lupus nephritis. (a) Total CIC's in serum from healthy controls (n=37), inactive SLE patients (SLEDAI=0) (n=13), patients with mild disease (SLEDAI 2.0 to ≤4.0) ...

SLE basophils express HLA-DR and home to lymphoid tissues

To investigate the activation state of basophils in SLE patients the marker CD203c was used as its expression is upregulated in activated basophils36. All SLE patients showed increased CD203c expression, relative to healthy controls, indicating that their basophils are active (Fig. 6a). CD62L expression was also increased on SLE basophils, and this was associated with increased disease activity (Fig. 6b). Expression of HLA-DR+ was also enhanced on SLE basophils (Fig. 6c, inset). This suggested increased homing of SLE basophils to the secondary lymphoid tissues. As shown in Fig. 6d, the absolute numbers of basophils in the circulation decreased in SLE patients. While this decrease was associated with immunosuppressive treatment (IST) (Supplementary Fig. 15), IST had no effect on the activation of basophils (as indicated by HLA-DR+). Importantly, basophils were found in the lymph nodes and spleen of the two SLE patients tested, but not of normals (Fig. 6e, f). The findings show that basophils in SLE patients are activated, and home to secondary lymphoid organs and express the appropriate molecules to present antigen. This is associated with the presence of self-reactive IgE in SLE patients.

Figure 6
Basophils in SLE patients are active, upregulate CD62L and HLA-DR, and home to secondary lymphoid organs. (a) Flow cytometric analysis of CD203c expression levels on blood basophils from healthy controls and inactive/mild/active SLE patients ((n=13/15/15) ...

Discussion

While SLE has long been considered a B cell disease, self-reactive T cells that promote B cell class switching37 and other cell types like dendritic cells, macrophages, etc.38,39 have also been implicated, for example, through secretion of factors influencing B cell survival and differentiation, such as BAFF and APRIL40. Here we demonstrate that the basophil is a key contributor to the production of self-reactive antibodies in SLE. Our findings in Lyn−/− mice demonstrate that depletion of basophils or the absence of IL-4 or IgE caused a marked reduction in autoantibody production and preserved kidney function. This suggests that without basophils the levels of autoantibodies are insufficient to cause kidney disease. Thus, basophils function to amplify the pre-existing loss of B cell tolerance.

Basophils have long been associated with allergy41,42. However, the role of the basophil in immunity has long been unclear. The recent discovery that basophils can induce TH2 cell differentiation in vivo18,43, amplify humoral memory responses44, and present antigen via MHC II32,34,43, provides evidence of a role for this cell type in regulating TH2 immunity. In the Lyn−/− mouse model, TH2-skewing is driven by the absence of Lyn kinase in the basophil, upregulating GATA-3 expression in these cells leading to copius production of IL-4 in vivo18. In humans, our preliminary analysis of the Lyn content in the basophils of SLE patients did not reveal significant differences relative to healthy controls (data not shown). However, there is increasing evidence of a role for Lyn kinase in SLE, particularly in populations of European descent23,24. Thus, further studies are required to determine the role of Lyn in human SLE.

Of particular interest is the finding that basophils contribute to the production of autoantibodies that cause lupus-like nephritis in the Lyn−/− mice. Activation of these cells caused enhancement of CD62L expression and their accumulation in the lymph nodes of Lyn−/− mice and SLE patients. MHC II expression on mouse and human basophils was increased, and in the mouse, expression of membrane-bound BAFF was observed, similar to what has been described in human basophils after engagement of IgD on their cell surface45. Depletion of these cells in Lyn−/− mice decreased splenic plasma cells and suppressed autoantibody production, which drives lupus nephritis29,30. Depletion of basophils also reduced the production of IL-1β, IL-4, IL-6, IL-13, and IFN-γ in the kidney of Lyn−/− mice. Thus, a reduction in the pro-inflammatory environment in the kidney suggests a possible therapeutic benefit from basophil inactivation or depletion.

Our findings show that IgE-ICs can activate basophils, and removal of self-reactive IgEs that form functional CICs (by deletion of the Igh7 locus or by eliminating IL-4 production) ablated kidney disease. These IgE-CICs were also associated with lupus nephritis in both Lyn−/− mice as well as in SLE patients. Given that circulating IgE levels can be reduced by an existing anti-allergy drug, omalizumab (Xolair®, Genentech), an anti-IgE antibody that functions to reduce circulating IgE levels and can cause decreased FcεRI expression on basophils46, a treatment with potential therapeutic benefit may already exist. While in SLE patients the association of increased levels of IgE anti-dsDNA antibodies with increased disease activity and active lupus nephritis strongly argues for a link between increased TH2 responses and development of nephritis in these patients, it is clear that TH1-mediated responses are also found in this patient population. The presence of increased circulating IgG1 and IgG3 autoantibodies demonstrates a strong TH1 component. This suggests that direct modulation of the TH2 response, such as by the use of IL-4 and IL-13 receptor antagonists47, as a therapeutic strategy could have the unwanted effect of exacerbating disease by shifting towards a TH1 (or possibly TH17) phenotype. Nonetheless, as we did not find the presence of IgE-CIC in the kidney's of Lyn−/− mice (data not shown), it appears that these CICs do not contribute to the kidney pathology per se but instead are important in basophil activation. Thus, perhaps, the strategy of IgE or basophil depletion may avoid the complications of altering the TH1/TH2 balance.

The view of SLE as a disease with a TH2 component has been controversial. There is considerable evidence for involvement of TH1 and possibly TH17 cells in SLE11,12,4850 as well as for the alteration or loss of regulatory T cell (Treg) activity9,51. Some mouse models of spontaneous SLE, like BXSB and MRL-Faslpr show increases in the TH1 cytokine IFN-γ as linked to the expression of the TH1 mediated isotypes, IgG2a and IgG3, and deletion of the IFN-γ gene in the context of these backgrounds was shown to eliminate disease4,49. Nonetheless, it is less well known that many of the spontaneous mouse models (NZB, NZW, BXSB, and MRL/Faslpr) of lupus-like disease have high circulating levels of IgE52, suggesting the possibility of a contributory role for a TH2 component in these models. SLE patients showed both TH1 and TH2 responses and both IgG-CIC's and IgE-CIC's were associated with increased disease activity. Several studies have suggested that the balance of TH1 and TH2 cell responses may determine the phenotype of lupus nephritis3,1113,48. A strong TH1 response was shown to be associated with diffuse proliferative lupus nephritis whereas a dominant TH2 response was associated with a membranous lupus nephritis. These observations argue that both TH1 and TH2 responses can contribute to lupus nephritis but the disease may manifest differently depending on the dominance of one or the other response.

Our findings show that basophils and the TH2 environment influences the production of autoantibodies and that the depletion of basophils or deletion of the Igh7 or Il-4 gene, in the context of Lyn-deficiency, caused a reduction in the circulating levels of these self-reactive antibodies. In SLE patients, self-reactive IgE is associated with active disease and active lupus, and basophils are active and were found in the secondary lymphoid tissues, of two tested individuals, where they can influence T and B cell function. Thus, our findings suggest the possibility that reduction of the circulating levels of self-reactive IgE or the dampening of basophil activity could have therapeutic benefit in lupus nephritis.

Online Methods

Mice

All animals used in the present study were described previously18. Unless otherwise noted, mice were aged for 32–40 weeks and were aged matched for group comparisons. Mice were maintained in specific pathogen-free conditions and used in accordance with NIH guidelines and NIAMS–approved animal study proposal A007-03-01.

Patients

Patient samples were collected from adult patients enrolled in a long term natural history study of systemic lupus erythematosus (SLE). The study was approved by the Institutional Review Board of NIAMS. All patients provided written informed consent. All patients fulfilled the American College of Rheumatology classification criteria for SLE53,54. Patient characteristics and lupus activity scoring system are shown in Supplementary Table 1 and Supplementary Methods. Control samples were obtained from random healthy blood donors.

Antibodies and flow cytometry

DNP-specific mouse IgE was produced as previously described55. All other antibodies were from commercial sources and are described in Supplementary Table 2. Flow cytometry acquisition was done with a FACSCalibur (BD Biosciences) as previously described18. Data analysis was with Flowjo software (Treestar Inc.).

In vivo basophil depletion and ex vivo analysis of splenic T cells

In vivo basophil depletion and ex vivo analysis of splenic T cells (CD4+) were previously described18.

Glomerulonephritis, analysis of glomerular deposition of CIC, and kidney function

Aged (~40 week old) mice were euthanized, kidneys were removed. One kidney was fixed with 10% buffered formalin (Sigma), embedded in paraffin, sectioned and stained with hematoxylin and eosin (H&E) (American Histolabs). The other kidney was placed in a vinyl mold in OCT medium and the sample was frozen in liquid nitrogen. Four-micrometer-thick frozen sections were fixed in cold acetone, blocked in PBS containing 1% bovine serum albumin (BSA) and stained in the same buffer with the specific fluorescein-conjugated antibodies or isotype controls (see Supplementary Table 2 for antibodies used).

For assessment of kidney function the albumin/creatinine ratio (ACR) was determined. Urine was collected from at least ten aged mice per genotype and the albumin concentration was measured with a mouse albumin ELISA (Bethyl laboratories). A creatinine assay (R&D systems) was used to determine urine creatinine concentrations. Results are expressed as ACR in μg of albumin per mg of creatinine.

Methods for assessment of glomerulonephritis and cytokine content in the kidney are described in Supplementary Methods.

Measurement of autoantibodies, CIC, and precipitation of CIC

Mouse anti-dsDNA IgG, mouse ANA IgG and mouse circulating immune complexes (CIC (C1q) IgG+A+M) ELISA kits were from ADI. ELISA for human circulating immune complexes (C1q coated plates) was from ALPCO and for human IgE was from Mabbiotech. All commercial ELISA's were performed according to the manufacturer's instructions. To measure both human and mouse, anti-dsDNA IgE and anti-dsDNA IgG subclasses, dsDNA coated plates (Calbiotech) were incubated with serial dilutions of serum in PBS containing 10% FCS (Invitrogen). The corresponding HRP-conjugated secondary antibodies were used (see Supplementary Table 2). Optical density at 450 nm was measured after TMB substrate incubation (Invitrogen). Data shown are from 1:200 dilution plates (where the best signal to noise ratio was obtained). The same approach was used to measure the levels of circulating anti-IgE IgGs in patient and healthy controls, using plates coated with human IgE (Abbiotec) at 2 μg ml−1 in PBS.

Circulating immune complexes (CIC) were precipitated from sera of aged mice as described previously31. Samples were analyzed by SDS-PAGE followed by Western blot using the indicated antibodies (see Supplementary Table 2). The LiCor Odyssey System was used to detect signal.

Basophil cultures, basophil detection, and measurement of IL-4 production

Bone marrow derived cultured basophils were previously described18. At day nine of culture, cells were washed, resuspended at one million cells per ml in medium containing only IL-3 and incubated overnight at 37°C. Cells were then resuspended in the same medium at five million cells per ml and stimulated as indicated. For IgE and antigen (IgE+Ag) stimulation, cells were sensitized with 1 μg ml−1 of IgE anti-DNP for 30 min, washed and then stimulated with 20 ng ml−1 of DNP-HSA (Sigma). For IgE-IC and IgG-IC stimulations, IgE- or IgG-containing immune complexes were prepared by incubating either IgE and anti-mouse IgE or IgG1 and anti-mouse IgG1 at 1:2 ratio for 30 min at 37°C (see Supplementary Table 2). The indicated concentration was then added to the cells for 4 hrs at 37 °C. Two hours prior to the end of this incubation, 10 μM monensin were added to the cells. Intracellular staining was previously described18.

Immunohistochemistry for basophil detection was performed as previously described56,57.

Statistical Analysis

For comparisons between two populations an unpaired two-tailed student t test was performed, unless otherwise specified. When three or more populations were compared, a one way ANOVA test was first performed and if significance was reached (p<0.05) an unpaired two-tailed student t tests was performed between each compared population, unless otherwise indicated. Statistical analysis was performed using GraphPad Prism 5.01 software.

Supplementary Material

Acknowledgements

We thank J. Daruwalla and G. Souto-Adeva (Office of Clinical Director, NIAMS) for patient samples, data input and analysis, and H.C. Oettgen (Harvard) for providing the Igh-7−/− mice. We also thank M. Hourseau (Hôpital Bichat, France) for patient sample preparation and Drs. L.B. Schwartz (Virginia Commonwealth University) and A.F. Walls (University of Southampton, UK) for the gift of human basophil specific monoclonal antibodies. We acknowledge the support of the Laboratory Animal Care and Use Section and the Flow Cytometry Section of the Office of Science and Technology, NIAMS. This research was supported by the intramural programs of NIAMS and NIDCR, NIH.

Footnotes

Competing Interests Statements The authors declare no competing financial interests.

References

1. Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med. 2008;358:929–939. [PubMed]
2. Moser KL, Kelly JA, Lessard CJ, Harley JB. Recent insights into the genetic basis of systemic lupus erythematosus. Genes Immun. 2009;10:373–379. [PMC free article] [PubMed]
3. Masutani K, et al. Predominance of Th1 immune response in diffuse proliferative lupus nephritis. Arthritis Rheum. 2001;44:2097–2106. [PubMed]
4. Balomenos D, Rumold R, Theofilopoulos AN. Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRL-lpr mice. J Clin Invest. 1998;101:364–371. [PMC free article] [PubMed]
5. Peng SL, Szabo SJ, Glimcher LH. T-bet regulates IgG class switching and pathogenic autoantibody production. Proc Natl Acad Sci U S A. 2002;99:5545–5550. [PMC free article] [PubMed]
6. Zeng D, Liu Y, Sidobre S, Kronenberg M, Strober S. Activation of natural killer T cells in NZB/W mice induces Th1-type immune responses exacerbating lupus. J Clin Invest. 2003;112:1211–1222. [PMC free article] [PubMed]
7. Nalbandian A, Crispin JC, Tsokos GC. Interleukin-17 and systemic lupus erythematosus: current concepts. Clin Exp Immunol. 2009;157:209–215. [PMC free article] [PubMed]
8. Pernis AB. Th17 cells in rheumatoid arthritis and systemic lupus erythematosus. J Intern Med. 2009;265:644–652. [PubMed]
9. Valencia X, Yarboro C, Illei G, Lipsky PE. Deficient CD4+CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol. 2007;178:2579–2588. [PubMed]
10. Zhao XF, et al. Increased serum interleukin 17 in patients with systemic lupus erythematosus. Mol Biol Rep. 2009 [PubMed]
11. Akahoshi M, et al. Th1/Th2 balance of peripheral T helper cells in systemic lupus erythematosus. Arthritis Rheum. 1999;42:1644–1648. [PubMed]
12. Heine G, et al. A shift in the Th(1)/Th(2) ratio accompanies the clinical remission of systemic lupus erythematosus in patients with end-stage renal disease. Nephrol Dial Transplant. 2002;17:1790–1794. [PubMed]
13. Shimizu S, et al. Membranous glomerulonephritis development with Th2-type immune deviations in MRL/lpr mice deficient for IL-27 receptor (WSX-1) J Immunol. 2005;175:7185–7192. [PubMed]
14. Tiller T, et al. Autoreactivity in human IgG+ memory B cells. Immunity. 2007;26:205–213. [PMC free article] [PubMed]
15. Tsuiji M, et al. A checkpoint for autoreactivity in human IgM+ memory B cell development. J Exp Med. 2006;203:393–400. [PMC free article] [PubMed]
16. Atta AM, Sousa CP, Carvalho EM, Sousa-Atta ML. Immunoglobulin E and systemic lupus erythematosus. Braz J Med Biol Res. 2004;37:1497–1501. [PubMed]
17. Odom S, et al. Negative regulation of immunoglobulin E-dependent allergic responses by Lyn kinase. J Exp Med. 2004;199:1491–1502. [PMC free article] [PubMed]
18. Charles N, et al. Lyn kinase controls basophil GATA-3 transcription factor expression and induction of Th2 cell differentiation. Immunity. 2009;30:533–543. [PMC free article] [PubMed]
19. Beavitt SJ, et al. Lyn-deficient mice develop severe, persistent asthma: Lyn is a critical negative regulator of Th2 immunity. J Immunol. 2005;175:1867–1875. [PubMed]
20. Hibbs ML, et al. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell. 1995;83:301–311. [PubMed]
21. Nishizumi H, et al. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 1995;3:549–560. [PubMed]
22. Yu CC, Yen TS, Lowell CA, DeFranco AL. Lupus-like kidney disease in mice deficient in the src family tyrosine kinases Lyn and Fyn. Curr Biol. 2001;11:34–38. [PubMed]
23. Lu R, et al. Genetic associations of LYN with systemic lupus erythematosus. Genes Immun. 2009;10:397–403. [PMC free article] [PubMed]
24. Liossis SN, et al. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus. J Investig Med. 2001;49:157–165. [PubMed]
25. Kopf M, et al. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature. 1993;362:245–248. [PubMed]
26. Oettgen HC, et al. Active anaphylaxis in IgE-deficient mice. Nature. 1994;370:367–370. [PubMed]
27. Asai K, et al. Regulation of mast cell survival by IgE. Immunity. 2001;14:791–800. [PubMed]
28. Kalesnikoff J, et al. Monomeric IgE stimulates signaling pathways in mast cells that lead to cytokine production and cell survival. Immunity. 2001;14:801–811. [PubMed]
29. Seshan SV, Jennette JC. Renal disease in systemic lupus erythematosus with emphasis on classification of lupus glomerulonephritis: advances and implications. Arch Pathol Lab Med. 2009;133:233–248. [PubMed]
30. Sinico RA, et al. Anti-C1q autoantibodies in lupus nephritis. Ann N Y Acad Sci. 2009;1173:47–51. [PubMed]
31. Toran EJ, Lee CM. Isolation and analysis of nephritic-producing immune complexes in Plasmodium berghei-infected mice. J Natl Med Assoc. 1995;87:693–699. [PMC free article] [PubMed]
32. Perrigoue JG, et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat Immunol. 2009;10:697–705. [PMC free article] [PubMed]
33. Sokol CL, et al. Basophils function as antigen-presenting cells for an allergen-induced T helper type 2 response. Nat Immunol. 2009;10:713–720. [PMC free article] [PubMed]
34. Yoshimoto T, et al. Basophils contribute to T(H)2-IgE responses in vivo via IL-4 production and presentation of peptide-MHC class II complexes to CD4+ T cells. Nat Immunol. 2009;10:706–712. [PubMed]
35. The American College of Rheumatology response criteria for systemic lupus erythematosus clinical trials: measures of overall disease activity. Arthritis Rheum. 2004;50:3418–3426. [PubMed]
36. Hauswirth AW, et al. Recombinant allergens promote expression of CD203c on basophils in sensitized individuals. J Allergy Clin Immunol. 2002;110:102–109. [PubMed]
37. Singh RR, Ebling FM, Sercarz EE, Hahn BH. Immune tolerance to autoantibody-derived peptides delays development of autoimmunity in murine lupus. J Clin Invest. 1995;96:2990–2996. [PMC free article] [PubMed]
38. Kyttaris VC, Katsiari CG, Juang YT, Tsokos GC. New insights into the pathogenesis of systemic lupus erythematosus. Curr Rheumatol Rep. 2005;7:469–475. [PubMed]
39. Holmdahl R, Tarkowski A, Jonsson R. Involvement of macrophages and dendritic cells in synovial inflammation of collagen induced arthritis in DBA/1 mice and spontaneous arthritis in MRL/lpr mice. Autoimmunity. 1991;8:271–280. [PubMed]
40. Levesque MC. Translational Mini-Review Series on B Cell-Directed Therapies: Recent advances in B cell-directed biological therapies for autoimmune disorders. Clin Exp Immunol. 2009;157:198–208. [PMC free article] [PubMed]
41. Schroeder JT, MacGlashan DW. New concepts: The basophil. J Allergy Clin Immunol. 1997;99:429–433. [PubMed]
42. Mukai K, et al. Basophils play a critical role in the development of IgE-mediated chronic allergic inflammation independently of T cells and mast cells. Immunity. 2005;23:191–202. [PubMed]
43. Sokol CL, Barton GM, Farr AG, Medzhitov R. A mechanism for the initiation of allergen-induced T helper type 2 responses. Nat Immunol. 2008;9:310–318. [PMC free article] [PubMed]
44. Denzel A, et al. Basophils enhance immunological memory responses. Nat Immunol. 2008;9:733–742. [PubMed]
45. Chen K, et al. Immunoglobulin D enhances immune surveillance by activating antimicrobial, proinflammatory and B cell-stimulating programs in basophils. Nat Immunol. 2009;10:889–898. [PMC free article] [PubMed]
46. Lin H, et al. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils. J Allergy Clin Immunol. 2004;113:297–302. [PubMed]
47. Burmeister Getz E, Fisher DM, Fuller R. Human pharmacokinetics/pharmacodynamics of an interleukin-4 and interleukin-13 dual antagonist in asthma. J Clin Pharmacol. 2009;49:1025–1036. [PubMed]
48. De Carli M, D'Elios MM, Zancuoghi G, Romagnani S, Del Prete G. Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity. 1994;18:301–308. [PubMed]
49. Kono DH, Balomenos D, Park MS, Theofilopoulos AN. Development of lupus in BXSB mice is independent of IL-4. J Immunol. 2000;164:38–42. [PubMed]
50. Peng SL, Moslehi J, Craft J. Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest. 1997;99:1936–1946. [PMC free article] [PubMed]
51. Lee HY, et al. Altered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology (Oxford) 2008;47:789–794. [PubMed]
52. Miyajima H, et al. IgE allotypes in sera of mice with autoimmune diseases and in mice with graft-versus-host disease after transfusion or bone marrow transplantation. Int Arch Allergy Immunol. 1996;111:152–155. [PubMed]
53. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725. [PubMed]
54. Tan EM, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–1277. [PubMed]
55. Liu FT, et al. Monoclonal dinitrophenyl-specific murine IgE antibody: preparation, isolation, and characterization. J Immunol. 1980;124:2728–2737. [PubMed]
56. Kepley CL, Craig SS, Schwartz LB. Identification and partial characterization of a unique marker for human basophils. J Immunol. 1995;154:6548–6555. [PubMed]
57. McEuen AR, Buckley MG, Compton SJ, Walls AF. Development and characterization of a monoclonal antibody specific for human basophils and the identification of a unique secretory product of basophil activation. Lab Invest. 1999;79:27–38. [PubMed]
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...